Market Research Report Title Publication Date Pages Price
Nocturia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Mycosis Fungoides - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Myelofibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Myasthenia Gravis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Nosocomial Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape 120 USD 2,250.00
Oral Mucositis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Hyperuricemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Hypersomnia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Hyperphosphatemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Optic Neuritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Idiopathic Pulmonary Fibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Opioid-Induced Constipation - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Interstitial Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Open-Angle Glaucoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape 120 USD 2,250.00
Helicobacter Pylori Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Hepatitis D - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Hereditary Angioedema - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Hemostasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Hot Flashes - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Human papillomavirus (HPV) Associated Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Hematopoietic Stem Cell Transplantation - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Hemophilia B - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Hypertriglyceridemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Fabry Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Febrile Neutropenia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Epithelial Ovarian Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Hairy Cell Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Erectile Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Esophageal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Gastrointestinal Stromal Tumor (GIST) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Gastric Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Chemotherapy Induced Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Chronic Kidney Disease (Chronic Renal Failure) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Endometriosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Biliary Tumor - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Chronic Liver Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Hereditary Angioedema - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Bipolar Disorder (Manic Depression) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Chronic Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Venous Thromboembolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Bacteremia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Aplastic Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Bacterial (Pyogenic) Meningitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Behcet's Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Aspergillosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Displaying 201 - 250 of 2417
Subscribe to Drug Pipeline